/news

XBiotech (XBIT) Gains 6.39% on June 22

Equities Staff  |

Shares of XBiotech Inc (NASDAQ: XBIT) are up 6.39% Wednesday.

As of 12:15:29 est, XBiotech sits at $6.09 and has moved $0.36 per share.

XBiotech has moved 0.36% over the last 30 days and has moved YTD 49.42% based on the prior day’s close.

The company anticipates its next earnings on 2022-08-08.

For technical charts, analysis, and more on XBiotech visit the company profile.

About XBiotech Inc

XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally occurring antibodies from patients with immunity to certain diseases. Utilizing natural human immunity as a source of new medicines offers the potential to redefine the standards of care for a wide range of diseases.

To get more information on XBiotech Inc and to follow the company's latest updates, you can visit the company's profile page here: XBiotech Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Will Mining Stocks Fall Further?
3 Reasons To Be Optimistic About the Global Shipping Industry
The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks



Market Movers

Sponsored Financial Content